Clinitech Laboratory Limited
Fixed Price IPO · BSE
- Price band
- ₹96 - ₹96
- Lot size
- 1,200 shares
- Issue amount
- ₹5.78 cr
- Total subscription
- 34.43×
- Opens
- 25 Jul 2024
- Closes
- 29 Jul 2024
- Allotment
- 30 Jul 2024
- Listing
- 1 Aug 2024
Offer at a glance
Issue overview
- Issue size
- 6,02,400 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,15,200
- Fresh issue
- ₹5.78 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,15,200
- Issue type
- Fixed Price IPO
- Shares before issue
- 16,80,000
- Shares after issue
- 22,82,400
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,200 | ₹1,15,200 |
| HNI | 2 | 2,400 | ₹2,30,400 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 2.74 | 0 |
| RETAIL | 0 | 127.45 |
| NIB | 2.74 | 61.34 |
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|
| EPS | 2.37 | 4.09 | 3.42 |
| ROE | 0 | 0 | 0 |
| ROCE | 0 | 0 | 0 |
| RONW | 10.46 | 25.75 | 27.74 |
| PRE IPO(PE) | 43.45 | 0 | 0 |
| POST IPO(PE) | 59.03 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Clinitech Laboratory Limited, established in 1990, runs 8 diagnostic centers across Thane and Navi Mumbai, offering a wide range of healthcare and diagnostic tests. The company conducts over 3 lakh tests annually in its NABL-accredited labs (National Accreditation Board for Testing and Calibration Laboratories), equipped with advanced technology and high-end equipment. Its Airoli, Navi Mumbai facility holds an ISO 15189:2012 accreditation certificate for quality testing services. As of December 31, 2023, Clinitech has a team of 74 employees dedicated to delivering accurate and reliable healthcare services.
Strengths
- NABL Accreditation: Clinitech Laboratory Limited's labs are approved by NABL, guaranteeing accurate and reliable diagnostic services.
- Diagnostic Centers Network: The company runs 8 modern diagnostic centers across Thane and Navi Mumbai, providing a wide range of healthcare services.
- Expert Leadership: Led by experienced promoters and management, the company has built a strong reputation with proven success in the healthcare industry.
Risk factors
- Brand Maintenance: If Clinitech Laboratory Limited doesn't maintain and grow its brand name and image, it could hurt the company's business and future opportunities.
- Quality Standards: If the company fails to consistently deliver high-quality services, it could negatively affect its business performance and financial health.
- Geographic Concentration: Since most of the company's operations are based in Thane and Navi Mumbai, any disruptions in these regions could impact its business and financial stability.
Promoters
Jagdish Umakant Nayak
Jyoti Jagdish Nayak
Registrar & documents
Lead manager
Inventure Merchant Banker Services Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
AL-1/545, Sector 16, Airoli, Opposite Radhikabai Meghe Vidyalaya, Navi Mumbai, Thane - 400708
+91 22 27792281
[email protected]Company website ↗Understanding CTLLAB IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.